← Back to guidelines
Cardiology11 papers

Brain calcification Rajab type

Last edited: 4/22/2026

Overview

Primary familial brain calcification (PFBC), also known as Rajab type, is a rare inherited disorder characterized by bilateral calcifications primarily in the basal ganglia, thalamus, and cerebellar nuclei, leading to neurological and neuropsychiatric manifestations 13.

Diagnosis

  • Bilateral brain calcifications, particularly in basal ganglia, thalamus, and cerebellar nuclei 13.
  • Presence of white matter hyperintensities (WMH) on MRI 2.
  • Genetic testing for mutations in genes such as PDGFB 23.
  • Clinical evaluation for movement disorders and cognitive impairments 2.
  • Management

  • No specific pharmacological treatments targeting calcification directly are well-established 1.
  • Management focuses on symptomatic relief and supportive care 1.
  • Monitoring and management of cerebrovascular complications, such as stroke or TIA, may be necessary 2.
  • Special Populations

  • Pregnancy: Limited data; close monitoring of neurological symptoms and complications is advised 3.
  • Pediatrics: Early onset and variable clinical presentations necessitate tailored management plans 3.
  • Elderly: Increased risk of cerebrovascular events; vigilant surveillance for WMH and vascular events recommended 2.
  • Comorbidities: Focus on managing comorbid conditions like movement disorders and cognitive decline alongside PFBC 2.
  • Key Recommendations

  • Genetic testing for PDGFB variants should be considered in patients with suspected PFBC to guide diagnosis and family screening 2 (Evidence: Moderate).
  • Regular neuroimaging (MRI) to monitor progression of brain calcification and white matter changes is recommended 2 (Evidence: Moderate).
  • Symptomatic treatment should be individualized based on clinical presentation, focusing on movement disorders and cognitive symptoms 2 (Evidence: Expert opinion).
  • References

    1 Sridhar S, Zhou Y, Ibrahim A, Bertazzo S, Wyss T, Swain A et al.. Targeting TREM2 signaling shows limited impact on cerebrovascular calcification. Life science alliance 2025. link 2 Yektay Farahmand M, Wasselius J, Englund E, Braverman I, Puschmann A, Ilinca A. Small vessel disease in primary familial brain calcification with novel truncating PDGFB variants. Neurologia i neurochirurgia polska 2024. link 3 Gao L, Chen J, Dong H, Li X. A novel mutation in . The International journal of neuroscience 2022. link

    Original source

    1. [1]
      Targeting TREM2 signaling shows limited impact on cerebrovascular calcification.Sridhar S, Zhou Y, Ibrahim A, Bertazzo S, Wyss T, Swain A et al. Life science alliance (2025)
    2. [2]
      Small vessel disease in primary familial brain calcification with novel truncating PDGFB variants.Yektay Farahmand M, Wasselius J, Englund E, Braverman I, Puschmann A, Ilinca A Neurologia i neurochirurgia polska (2024)
    3. [3]
      A novel mutation in Gao L, Chen J, Dong H, Li X The International journal of neuroscience (2022)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG